Attorney General Jeff Sessions made an announcement at a news conference Tuesday that the Justice Department will be creating a new task force to pursue the makers and distributors of prescription opioids. It seems that beyond pursuing new restrictions being put on prescriptions, there will be a more intentional focus on Big Pharma and those who many believe have made the opioid crisis possible.
Jeff Sessions said the task force will “examine existing state and local government lawsuits against opioid manufacturers to determine if we can be of assistance.”
Meanwhile, Sessions also included the Justice Department is going to be backing a lawsuit in Ohio against major prescription opioid makers.
Ohio VS Opioid Makers Lawsuit
In truth, this lawsuit isn’t just about the state of Ohio. It consolidates more than 400 complaints by cities, counties and Native American tribes nationwide. Buckeye Nation has definitely been hit hard by the opioid crisis, but for now, the stage is set here for a massive effort against questionable practices from opioid makers.
The lawsuit that solicits the Justice Departments attention is pending in Federal District Court in Cleveland. It goes after various companies for using misleading marketing to promote prescription opioids, including:
The lawsuit also accuses the defendants of:
- Downplaying the risk of addiction to these drugs
- Failing to report suspicious orders by consumers, which would indicate the drugs were being abused
Furthermore, there are some big names in Big Pharma being listed as defendants, including:
- Johnson & Johnson
- Purdue Pharma
- Teva Pharmaceuticals
The suit is also going after large distributors, such as:
Not to mention pharmacy chains like:
So how will the Justice Department be engaging in the current lawsuit? How will this new development impact the outcome of the case?
For more important information on the dangers of prescription drugs, download our
FREE E-BOOK “Big Secrets of Big Pharma: Why They Secretly Hope You Get Hooked”
DOWNLOAD FREE E-BOOK
Statement of Interest Against Opioid Makers
During the press briefing, Sessions explained that the Justice Department plans to file what is called a “statement of interest” in the Ohio lawsuit. This is a technique that past administrations typically would only resort to in cases that directly affect the federal government’s interests, such as diplomacy and national security.
However, with the intensity of the opioid crisis being what it is, it is perfectly understandable to make it such a high priority for the current administration to get involved with. So far, recovery advocates have been largely unimpressed with the half-measures that have been presented thus far with the Trump administration to address the issue.
By invoking the statement of interest, the attorney general is legally able to argue on behalf of the government’s interest in any court in the country. However, it does not make the government a plaintiff. All things considered, Sessions said his department will use criminal and civil penalties. He states,
“We will use whatever tools we have to hold people accountable for breaking our laws.”
Which is quite a statement, considering it isn’t at all common for criminal charges to be brought against Big Pharma.
The Devil Is in the Data
What brought the Justice Department into this began with a discussion on access to certain data. This past Monday, lawyers for the Drug Enforcement Administration (DEA) came to the Ohio courtroom to discuss how much data they would share about the national distribution of painkillers.
The DEA said it would only provide two years of information in the case, asserting that the agency did not want to compromise ongoing criminal investigations. However, Judge Dan Aaron Polster’s request is to provide the sides with nine years of data. He said the agency has until next Monday to decide whether it will comply. This data can assist in determining:
- The number of pills distributed
- The locations
- The distributors
This information could be crucial in allocating liability.
Richard Fields, a lawyer who represents state attorneys general and sovereign Native American nations in opioid litigation, predicts that the statement of interest from the Justice Department “will help unlock this data so that we can hold manufacturers, distributors and pharmacies accountable for flooding communities with pills.”
Therefore, it appears Sessions is going to be taking some big steps toward calling out Big Pharma for their involvement in the opioid crisis. Sessions says the government will be taking a hard look at doctors who overprescribe prescription painkillers. Even legal drugs like these too often lead to addiction and abuse of illegal drugs like heroin.
Ohio Attorney General Mike DeWine says he believes this is a game changer. With all the suffering communities in Ohio have seen over the past several years, we can only hope.
Holding Big Pharma accountable is a huge step. Nevertheless, we should also highlight the need for state and community officials to promote safe and effective addiction treatment. Innovative and holistic recovery programs can make a dramatic difference in helping heal communities. If you or someone you love is struggling, please call toll-free now.
CALL NOW 1-888-922-5398
Right now a few American cities are aiming to establish active safe injection sites, with most recent reports indicating the first will probably be San Francisco. Currently, the Golden Gate City is on track to open two of these facilities in July. Meanwhile, Philadelphia is not far behind as city officials are pushing forward with a proposition from January. Other areas fighting for the controversial programs include Seattle and Baltimore.
Now it seems this fight for safe injection sites may soon pit state governments against the federal government, as the DEA under the Trump administration vows to take action against these facilities.
Safe Injection Sites for San Francisco
The city of San Francisco has an estimated 22,000 intravenous drug users. As of now, it has become the norm to see people injecting drugs in broad daylight on a park bench, public transit, or any sidewalk. As a consequence, dirty needles get left out in the open. So the decision by San Francisco officials to establish safe injection sites isn’t all that alarming.
Safe injection sites mean fewer needles on the streets. Reports from public health officials expect that 85% of the intravenous drug users in the city would use these sites, and the city could potentially save $3.5 million a year in medical costs. According to the director of San Francisco’s Department of Public Health, Barbara Garcia, officials are already working out the details. Garcia is currently working with six to eight nonprofits that already provide needle exchange programs and other addiction services. Two of them will soon be operating as safe injection sites.
Garcia says that because the cities fiscal year will begin on July 1, the process of opening these safe injection sites should begin close to that date. She also adds that once officials are able to examine how the first two sites are working, they can decide if and when to open the third and fourth sites.
Because intravenous drug use is still against state and federal law, the city will be avoiding liability by funding these sites through private investments. Garcia did not include where the money would be coming from. Garcia also does not appear to be too concerned about whether opening safe injection sites will draw the ire of the Trump administration, saying,
“That’s to be seen. I’m more worried about people dying in our streets.”
Given the rates of intravenous drug use and overdose death in the area, that sounds like a reasonable reason to worry. Part of operating safe injection sites also means providing a supervising medical staff equipped with overdose antidotes, and offering addiction treatment resources to those willing to seek help.
Hope for Harm Reduction
State Senator Scott Wiener is also working to get state law changed to ensure that anybody associated with safe injection sites won’t face arrest or punishment, including:
- Property owners
- Drug users themselves
The bill Wiener is pushing was last year passed in the Assembly, but remains two votes short of confirmation in the Senate.
Part of the reason for so many officials pushing to protect and advance this project seems to come from a fair amount of public support. For the first time, the Chamber of Commerce’s Dignity Health CityBeat Poll included a question about safe injection sites this year. It asked respondents whether they support or oppose-
“drop-in facilities called safe injection sites where intravenous drug users could use their drugs, off the street, and in a place where medical and social services are available.”
Out of all those who answered the survey:
- 67% of respondents said they support the idea
- 45% of those were ‘strongly’ supportive
- 22% of those were ‘somewhat’ supportive
- Only 27% percent opposed it
- 6% didn’t know
The poll found support for the sites regardless of:
The demographics also includes support from:
- Even 42% of self-described Conservatives
Mayor Mark Farrell is another supporter who said,
“I understand the misgivings around it and some of the rhetoric from people who don’t support it, but we absolutely need to give it a try.”
While issues like homelessness, crime and gang violence were all concerns consistent with opening of injection sites, city officials seem to believe the old way isn’t working. The hope is that by providing social services and treatment options, these safe injection sites will not only save lives but help more people get off drugs that otherwise might not have access to these resources.
Trump Says Sites Will Face Legal Action
It still seems these efforts will be met with resistence from the federal government. Last week the Trump administration made it clear they reject any facilities where heroin users can inject drugs under supervision. The president and his Attorney General Jeff Sessions seem to be committed to their ‘law and order’ approach to the drug problem, despite any lessons learned by the failed War on Drugs.
One might note that in general, the U.S. Drug Enforcement Agency views safe-injection sites as facilitation of criminal behavior. Therefore, it’s an absolute possibility the DEA will take some kind of enforcement action against any safe injection sites that pop up in the states. Katherine Pfaff, a DEA spokesperson, argued that these programs remain federally prohibited. She states,
“Supervised injection facilities, or so-called safe injection sites, violate federal law. Any facilitation of illicit drug use is considered in violation of the Controlled Substances Act and, therefore, subject to legal action.”
However, it appears some of the states that have approved safe injection sites are already preparing to do legal battle with Attorney General Jeff Sessions and his Justice Department to convince the courts that this public health emergency is far too critical to pass up any opportunity at harm reduction.
So, what is going to become of this new controversy? More people, including law enforcement officials and conservatives, could be warming up to the idea of cleaning up the streets with safe injection sites in some states. If the DEA make moves to shut them down, what will happen next? Are safe injection sites an acceptable form of harm reduction? If not, what else could help address the opioid crisis?
Let us know in the comments what you think about these programs.
Palm Healthcare Company believes in providing an effective, holistic treatment program to help those suffering who need help. Providing safe and comprehensive care should always be a focus in the effort to overcome the drug problem, and preservation of life should always be a priority. If you or someone you love is struggling, please call toll-free now.
CALL NOW 1-888-922-5398
Last week we reported on the story of President Trump’s Attorney General Jeff Sessions rescinding a marijuana memo from the Obama administration that established a policy of refraining from federal interference with state laws concerning marijuana use. Once the announcement hit the internet, people from all sides of the argument began chiming in with either praise for the “rule of law” stance of this administration, or adamant opposition of this new policy that essentially reignites the “war on weed” in America.
This announcement came only days after the state of California had officially enacted the legalization of recreational marijuana. Needless to say, the conversation has not yet been dismissed. One voice came from the American Civil Liberties Union (ACLU).
American Civil Liberties Union VS Sessions
For some background, the American Civil Liberties Union is a nonpartisan, nonprofit organization with a stated mission:
“to defend and preserve the individual rights and liberties guaranteed to every person in this country by the Constitution and laws of the United States.”
The ACLU has over one million members and works through litigation and lobbying while providing legal assistance in cases when it considers civil liberties to be at risk.
In response to the news of Jeff Sessions rescinding the Obama-era policy for a hands-off approach to legal marijuana states, the deputy director of the American Civil Liberties Union, Jesselyn McCurdy stated:
“Criminalizing marijuana may be a priority for Attorney General Sessions—who has spent decades using bad science to push his own regressive agenda—but it is not a priority for the American people, 52 percent of whom support legalization. Rescinding this guidance is yet another example of how this administration’s ‘law and order’ philosophy is deeply out of touch with most Americans. With today’s decision, the Department of Justice is essentially telling at least six states and the District of Columbia that they are not entitled to govern as they see fit when it comes to drug policy. For politicians who purport to believe in ‘small government’ and states’ rights, this is a wildly incongruous move.”
Later on in the statement, McCurdy concludes,
“The War on Marijuana, like the War on Drugs, has failed by almost every measure—with the exception of successfully destroying communities of color. Marijuana criminalization negatively impacts public housing and student financial aid eligibility, employment opportunities, child custody decisions, and immigration status. Today’s decision furthers entrenches the country in racially biased, fiscally irresponsible, and morally wrong drug policy—and the ACLU will continue to fight it.”
And the ACLU is most definitely not alone in this mindset. Both Democrats and Republicans are openly criticizing this shift, with some like Senator Cory Gardner promising to oppose it at every opportunity.
Compassion Not Punishment
The backlash from this most recent decision from Jeff Sessions has come from all directions. Pretty much every publication and news outlet has covered this controversial move. As of now, there is no definitive answer as to how this policy change will impact those states where medical marijuana use is legal, or how it will impact the recreational marijuana industry.
But despite the fact that marijuana has become increasingly supported for medicinal use across the country, with many advocating for recreational use as well, the reality remains that drugs can still be abused, regardless of their legal status.
According to the National Institute on Drug Abuse (NIDA), marijuana use can lead to an individual developing problems known as marijuana use disorder. Data from recent studies research suggests:
- 30% of those who use marijuana may have some degree of marijuana use disorder
- Use of marijuana before age 18 makes someone 4-7 times more likely to develop marijuana use disorder
The NIDA also states that marijuana dependence occurs when the brain adapts to large amounts of the drug by reducing production of and sensitivity to its own endocannabinoid neurotransmitters. In 2015:
- About 4.0 million people in the United States met the diagnostic criteria for a marijuana use disorder
- Only 138,000 voluntarily sought treatment for their marijuana use
So while some may still experience difficulties due to their use of marijuana, the focus should still remain on support and assistance through compassionate care and treatment, not punishment. Regardless of whether you support the decision of the attorney general, or if you stand with the American Civil Liberties Union and other legalization advocates, you can support compassionate and comprehensive treatment for those who do struggle with substance use disorder.
Marijuana use disorder is a real condition for some people. If you or someone you love is struggling with a substance use disorder, such as chemical dependency or addiction, please call toll-free now to speak with a specialist today. We want to help!
CALL NOW 1-888-922-5398
Before the hype around recreational use of marijuana in California could even begin to dwindle, new reports are stating that President Trump’s Attorney General Jeff Sessions is planning to begin a federal crackdown on marijuana laws.
Jeff Sessions is set to announce today that he is rescinding memos sent out from the Obama administration that established a policy of non-interference with state laws concerning marijuana use. For some time now there have been several stories highlighting Jeff Sessions’ disagreement with allowing states to decide their own laws concerning medical or recreational marijuana use. Some sources indicate he has been planning a new strategy that will actually bring federal law to a head against state marijuana policies.
UPDATE: According to The Washington Post, Jeff Sessions notes in a memo sent to U.S. attorneys that federal law prohibits the possession and sale of marijuana. Sessions undid four previous Obama administration memos that advised against bringing prosecutions in states where marijuana was legalized to use for recreational or medical purposes. Sessions said prosecutors should use their own discretion in weighing whether charges were appropriate.
So what does all this mean for marijuana states?
The Obama Era Policy
The memo essentially describing the Obama-era policy through the Justice Department is known as the “Cole Memo”. It was named after then-Deputy Attorney General Jim Cole in 2013.
The “Cole Memo” outlined new priorities for federal prosecutors in states legalized use of marijuana. These shifts in policy represented a major change from the strict enforcement approach of past administrations to an attitude of non-interference. Back in 2014 U.S. Congress approved legislation preventing the DEA from carrying out any raids, arrest, or prosecutions of patients using medical marijuana. Congress also blocked law enforcement agencies under the Justice Department from consuming federal dollars in efforts to enforce federal marijuana laws in states that have legalized the use of medicinal marijuana. Under President Barack Obama, the Department of Justice did not pursue action against states that legalized recreational marijuana use. In 2015 there was a bipartisan effort in Congress to block the DEA from using federal funding for aggressively pursuing marijuana in the states where it was legalized.
The Obama era outline essentially allowed states to decide whether or not to legalize marijuana and to what extent. The federal prosecutors would not intervene as long as the state regulations did not threaten other federal priorities. So the distribution of marijuana to minors and cartels was still prohibited.
So with this announcement, many are wondering if Jeff Sessions will be working to undo other changes as well.
The Jeff Sessions Reversal
At the time of writing this article, whether or not Jeff Sessions will offer up a new strategy for dealing with marijuana-friendly states or not has yet to be seen. At this time the great concern is how this announcement may end up putting state and federal law in conflict, and what to expect out of enforcement from the federal government.
But many say this is a frustrating development, especially considering that President Trump has said in the past that he would not allow his attorney general to change the current policy, telling a reporter that,
“I’m a states person. I think it should be up to the states, absolutely.”
If we go back to February of 2017, Sean Spicer suggested in a press conference that the Trump administration and the Justice Department already had the intentions to no longer turn a blind eye to states with their own legal marijuana laws. At the time Spicer said the Trump administration would be “taking action” against these states. Contradicting all the talk of states’ rights and rolling back federal enforcement.
Many are wondering if President Trump was consulted about this decision, or if he has been made aware of the implications of this change. Especially since it goes against his original campaign promise to leave marijuana laws to the states.
This move would lay the groundwork for the federal government to begin a crackdown on the rapidly increasing marijuana industry all across the country. If these reports are confirmed this afternoon with no new innovations in their place, this move could have a drastic impact on the economics around the marijuana industry.
Sessions Track Record
However, this should all come as no surprise, since Jeff Sessions has repeatedly spoken out against decriminalization of marijuana and a return to the failed tactics of the War on Drugs at every turn.
In fact, a key adviser on marijuana policy to Jeff Sessions, Dr. Robert DuPont, believes drug testing should be a routine part of primary-care medicine. He has gone as far to suggest that primary-care physicians should be given the power to force some patients into treatment against their will. DuPont also suggests the following treatment to subject individuals to monitoring and random drug tests for up to 5 years.
Dr. Robert DuPont was among a small group of drug-policy experts involved last month in a closed-door meeting with Sessions to discuss federal options for dealing with the rapid liberalization of state marijuana laws.
The Marijuana States
Eight states and the District of Columbia have laws allowing for personal consumption of marijuana for recreational purposes. 28 states and the District of Columbia have legalized marijuana for medical use. Even more states recently have begun to talk about changes in their own policies. California voters pushed through legislation to legalize recreational use back in November of 2017, and with the start of the New Year, those laws went into effect. Now, not even a week later, the fate of this state’s new policy is hanging in the balance.
Needless to say, marijuana advocates all over the nation are troubled by this news. According to NORML Political Director Justin Strekal,
“If the Trump administration goes through with a crackdown on states that have legalized marijuana, they will be taking billions of dollars away from regulated, state-sanctioned businesses and putting that money back into the hands of drug cartels,”
But some states are not ready to give up on their marijuana laws. Other Republicans, such as Colorado Senator Cory Gardner, are avidly speaking out in opposition to the recent decision by Jeff Sessions. Senator Gardner has vowed to prevent any new appointees for the Department of Justice from being confirmed until this reversal has been reversed.
Hopefully, when Jeff Sessions makes his official announcement, we will have some more clarity on how the federal government plans to address marijuana use going forward.
While the legal status of marijuana may soon be up for a serious debate, the fact remains that it is still possible to abuse marijuana. Whether a drug is legal or not, there are still risks. There are already plenty of legal drugs that cost thousands of lives every year. When substance use becomes habitual it can be extremely harmful to an individual who struggles with substance use disorder. Even though marijuana is not claiming lives like the opioid epidemic, for some it has adverse effects on the quality of life.
While marijuana is not considered to be as dangerous as other illicit drugs, such as heroin or methamphetamines, it can cause dependence for people who use the drug. The typical consensus that marijuana is not as physically destructive and addictive as other “harder” drugs doesn’t change the fact that psychiatrists also believe the psychological impacts of a substance do matter when talking about an addiction. These effects can be just as detrimental.
Marijuana addiction treatment offers a safe and secure environment while providing a variety of therapeutic opportunities to help develop a healthy lifestyle without relying on the use of marijuana or other drugs.
There still needs to be resources available to help people who suffer from abuse. Supporting addiction recovery means breaking the stigma and offering holistic and effective solutions. Palm Healthcare Company is here to help. If you or someone you love is struggling, please call toll-free now.
CALL NOW 1-888-922-5398
This past Wednesday, Attorney General Jeff Sessions made the announcement that White House counselor Kellyanne Conway will be the Trump administration’s go-to for opioid crisis efforts. This announcement has been met with both praise and criticism. Some say this appointment actually gives validity to the White House’s commitment to solving the ongoing opioid epidemic, while others see it as the exact opposite.
For a little background, Kellyanne Conway worked as a pollster before becoming Trump’s campaign manager during his run for the 2016 presidential nomination. Currently, Conway serves as a White House spokeswoman and Trump surrogate. She has been seen on countless panels discussing the biggest topics and politics. She absolutely has her work cut out for her, so can Kellyanne Conway compete?
The Kellyanne Cons and Pros
So can this infamous Trump advocate, the woman who practically accidentally coined the phrase “alternative facts” compete with the opioid crisis in America? Kallyanne Conway has become notorious for defending some of President Trump’s most flagrant and controversial “alternative facts” in the media. But in her defense, she also has said some things that seem to highlight important prospects for this problem.
So here are some things to consider when we talk about Kellyanne Conway being put in charge of the opioid epidemic.
Lack of Experience
One of the big problems with this appointment people are pointing out is the lack of experience. Critics say this appointment speaks to how little passion the current administration is actually putting into fighting the opioid crisis since Kellyanne Conway has no experience in public health or with drug policy.
But in a time where Americans seem to be putting more trust in people that don’t typically meet the description of “qualified” in hopes that an outsider might bring better results, it makes sense that a lot of people might still hope Kellyanne can do some good.
Yet, there are still those who aren’t so sure. Tom Synan, a police chief and member of the Hamilton County Heroin Coalition in Ohio tweeted in response to the announcement:
“Ummm… did we run out of Dr’s, cops, addiction specialists or people who are actually dealing with this on the street to lead this?”
As a first responder, Synan is one of many people who are frustrated with the current actions being taken.
“I don’t want to get involved in politics, but it seems like it is a political position … I think I would have gone out to the country and tapped into people who are national experts who are on the street who are literally dealing with this issue every day,”
It seems many on the front lines are not impressed with the Trump administration’s move to put Kellyanne Conway in charge of efforts to combat one of the worst drug problems in the nation’s history.
Publicity and Perception
During a press briefing about the Justice Department’s efforts to combat the crisis where the announcement was made, Sessions said President Donald Trump chose Kellyanne Conway to “change the perception” about opioids and reduce addictions and deaths.
According to Sessions, President Trump has made the epidemic “a top priority for his administration, including every senior official and Cabinet member.”
An opioid policy expert Andrew Kolodny of Brandeis University actually defended the move when speaking to BuzzFeed News, stating:
“It is a positive sign. She is a high-profile figure in the administration, showing the administration takes this seriously,”
Some believe this can offer a sign of hope for more concrete action since many recovery advocates say despite the declaration of a public health emergency from President Trump there has been very little action taken to change the state of the epidemic.
Bertha Madras, a member of the President’s Commission on Combating Drug Addiction and the Opioid Crisis and Harvard Medical School professor, said:
“The most important thing that Kellyanne Conway will provide is access … but also commitment… She was at all the meetings, she listened and took copious notes.”
Let’s hope those are some good notes because thus far the opioid problem in America has shown no signs of slowing down. Jeff Sessions justified the appointment by saying Kellyanne Conway “understanding messaging” and can help turn around public perception. But is this about publicity, or is it about the preservation of life?
Surely breaking the stigma and changing the way addiction is viewed does matter, but should someone who specializes in making things look good to be in charge of how this country deals with one of the most prominent crises we face?
Treatment and Resources
Kellyanne does seem to support treatment, but to what extent it is still unclear. In one interview with ABC Kellyanne Conway did say,
“Pouring money into the problem is not the only answer. We have to get serious about in-facility treatment and recovery.”
So she at least appears to understand how crucial effective inpatient treatment is for recovery.
But when reporters mentioned the fact that there needs to be funding for these programs, she put more emphasis on “a 4 letter word called will” that seems to side-step the question- where will these resources come from?
As it now stands, White House has:
- Left the leadership role of the Office of National Drug Control Policy vacant
- Failed to release any written opioid-control strategy
- Not requested funds to replenish the national public health emergency fund that currently sits at just $66,000
In fact, President Trump’s 2018 budget request would increase addiction treatment funding by less than 2%. And don’t be fooled, that increase includes the $500 million already appropriated by Congress in 2016 under the 21st Century Cures Act with the Obama administration.
Even Chris Christie, the Republican New Jersey Governor who led the White House Opioid Commission, said:
“In New Jersey, we are spending $500 million,” he said. “I am not, quite frankly, impressed with $1 billion from the federal government for the nation.”
Strict Prevention and Punishment
When you look at what she has said on record in regards to opioids and addiction, it doesn’t really inspire a great deal of confidence. Kellyanne Conway has consistently hinted to an outdated ideology of what addiction is and how to address it.
In the past, Kellyanne has said,
“The best way to stop people dying from overdoses and drug abuse is by not starting in the first place… That’s a big core message for our youth.”
That’s right; just say no.
Critics say this aligns with the mindset of Jeff Sessions and others in the White House who seem to think that ‘Just Say No’ tactics actually work, or that purely prevention-based programs like D.A.R.E. can solve the whole problem. While prevention is important, it has proven to be ineffective as a focal point when addressing addiction.
Circling back to publicity, what Ms. Conway does seem to heavily endorse is a White House investigation for a “national ad campaign” on abuse prevention. President Trump himself had voiced his own support for a national advertising initiative to try and deter drug use.
But we all remember those commercials- this is your brain on drugs- and they didn’t really help that much.
Again, it seems Attorney General Sessions and the current administration is more focused on punishment than treatment and strict law enforcement. Sessions said the Justice Department was giving more than $12 million in grants to state and local law enforcement to help them prosecute crimes connected to:
Sessions is also ordering all U.S. Attorney offices to designate opioid coordinators. Kaitlyn Boecker, Policy Manager with the Drug Policy Alliance, has been vocal in her disapproval of the current steps being taken.
“Despite declaring the opioid overdose crisis a public health emergency just last month, the Trump Administration continues to emphasize failed prohibitionist policies while ignoring proven public health measures that we know reduce overdose death, like community naloxone distribution.”
“As we feared, the Administration is using the overdose crisis as an excuse to ratchet up the war on drugs rather than an opportunity to save lives.”
At this point, we can say that the news is not without skeptics. While many are still trying to remain hopeful that maybe because Kellyanne is so vocal and such a well-known surrogate for the president that perhaps she will be able to garner more attention to the issue.
While the fight for more resources continues, we should always encourage people to seek help. There are many safe and effective treatment resources already that have been helping people recover from drug and alcohol addiction for decades, like Palm Healthcare Company. If you or someone you love is struggling, please call toll-free now. We want to help.
CALL NOW 1-888-922-5398